Louise Brook Clinical Trials Quality Monitor. Date
|
|
- Reginald Mosley
- 5 years ago
- Views:
Transcription
1 Details: Author: Louise Brook Clinical Trials Quality Monitor SOP Pages: 12 Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person approving this SOP. Date Signature of the person approving this SOP. 1.0 Professor Stephen Smye Director of R&I Leeds Teaching Hospitals NHS Trust 1.0 Clare Skinner Research Manager Faculty of Health and Medicine The University of Leeds Distribution & Storage: Distribution to Any Research Staff conducting or assisting with a CTIMP trial within Leeds Teaching Hospital NHS Trust Location of Document Paper: Electronic: Quality Assurance, Research and Development, Leeds General Infirmary I:\QA\1_SPONSOR_LEEDS_DOCUMENTS\SOPs/ R&I website V1.0 (131021) Page 1 of 12
2 Contents Page 2 Section A - Introduction Page 3 Section B - Applicability Page 3 Section C - Pages Setting up your Investigator Site File (ISF) / Trial Master File (TMF) Pages Filing and updating documentation throughout the trial Pages Documentation to be stored following trial closure Page General Trial Documentation Tips Page As an Investigator you must ensure the following Page 11 Section D - References Page 12 Section E - Definitions Page 12 V1.0 (131021) Page 2 of 12
3 Please note: This SOP should be used and followed in conjunction with other LTHT SOPs developed for researchers to support study set up and management. These can be found on the LTHT website or by contacting R&I directly. For clinical trials where Leeds is not the trial Sponsor you may use these SOPs as guidance, but refer to any Sponsor SOPs for further information. Section A Introduction 1.1 This Standard Operating Procedure (SOP) acts as a guide for all researchers to aid with TMF / ISF set up and maintenance when conducting a Clinical Trial of an (CTIMP) within Leeds Teaching Hospitals Trust (LTHT) and the University of Leeds (UoL). 1.2 This SOP should support standardisation and continuity between all members of staff working within research teams across LTHT / UoL and increase awareness as to how to maintain trial documents in accordance with Good Clinical Practice (GCP) and local procedure. 1.3 A Trial Master File (TMF) and/or an Investigator Site File (ISF) should be established at a beginning of a trial and contain all essential documents. It is the responsibility of the Investigator / delegated staff member to ensure the file is actively maintained and updated until trial closure. Filing documents with the investigator/institution and Sponsor in a timely manner can greatly assist in the successful management of the trial by the Investigator, Sponsor and Monitor (GCP E6 8.1). 1.4 ICH GCP section 8.1 states that the essential documents to be filed are those documents which individually and collectively permit the evaluation and conduct of a trial and the quality of the data produced. These documents serve to demonstrate compliance of the Investigator, Sponsor and Monitor with the standards of Good Clinical Practice and with all applicable regulatory requirements. Every trial is different and therefore the content of each TMF / ISF may vary. This SOP is designed to support researchers with decisions related to the set up and maintenance of an individual trial. 1.5 A template TMF index is available from the R&I Quality Assurance (QA) department and R&I website. This SOP will provide additional detail on various sections of the index, highlighting further information that may be relevant. At the end of the SOP you will also find general advice, tips and rules. Section B Applicability 1.1 All members of research staff involved in running CTIMP trials within LTHT including, but not restricted to: Chief and Principal Investigators (CI/PI), Research Nurses, Trial Coordinators / Assistants and Monitors. 1.2 The Investigator has ultimate responsibility for ensuring that all applicable site staff adheres to this SOP. V1.0 (131021) Page 3 of 12
4 1.3 Section C 1.0 Setting up your Investigator Site File (ISF) / Trial Master File (TMF): 1.1 The initial approvals, forms and supporting documentation submitted as part of the trial set up process must be retained and stored for future reference. It is therefore recommended you set up your Investigator Site File (ISF) at this time point. Guidance on the documents R&I require prior to granting NHS approval can be located on the R&I website. 1.2 The file must contain all essential documents pertaining to the trial. A minimum list of essential documents which must be maintained and filed can be located in section 8 of the ICH GCP E6 document, together with a brief description ( essential-documents-for-the-conduct-of-a-clinical-trial). Use this list as a checklist when constructing / maintaining your ISF, however please note it is not a definitive list 1.3 The ISF/TMF should be labelled with the trial title, R&I number and any other trial identifiers. You should label each file / box / binder with the volume number and sections contained e.g. ISF, Vol 1 of 2, Sections Each file should contain a site file index for easy navigation. Dividers can be used to clearly identify sub sections. 1.5 Local approval documents e.g., the R&I form, SSI form, Pharmacy Able to Support letter, evidence of approval from all support departments and correspondence between the research team / R&I and Sponsor should be filed within the ISF at the start of the trial. Additional documents are then added throughout the life of the trial. 1.6 Your study file should be located in a locked storage facility with access restricted to research staff. 1.7 Prior to commencing the trial please plan how much storage space will be required, taking into account the volume of paperwork likely to be generated (volume of CRFs etc.) 2.0 Filing and updating documentation throughout your trial: 2.1 Personnel and Key Contacts: This section should list the main contact details for the research team including, where appropriate: The CI/PI, Sponsor, Trial Coordinator / Assistant, Data Manager, Lead Pharmacist This list must be updated by the member of staff delegated the responsibility of Site File Maintenance when any changes to the above contacts occur. V1.0 (131021) Page 4 of 12
5 2.2 Protocol (final and amendments): The initial protocol and any amendments must be reviewed and agreed by the trial Sponsor prior to submitting the document to the Research Ethics Committee / Medicines and Healthcare Products Regulatory Agency (MHRA) This section should include copies of all previously approved versions of the trial protocol used throughout the trial. If many amendments occur, superseded versions may be stored separately (or electronically) to save space in the main ISF (providing a file note is created documenting the alternate location. In these circumstances it is beneficial to store the signature page for the previous protocols in the ISF/TMF GCP (E6 section 8.2.6) states that the trial protocol must be signed to document Investigator and Sponsor agreement to the protocol / amendments, therefore please include a signature page for this purpose on the protocol. Complete a signature page for each new protocol held in the ISF / TMF after an amendment Please see the template protocol on the R&I website for guidance on protocol contents and format Version control all formal trial documents using the document footer. When an amendment is required update both the version number and date to allow amendments to be tracked (e.g. Protocol Version 1 (01/09/2013) would become Protocol Version 2 (12/09/2013) following an amendment.) Superseded documents should always be marked as such to avoid accidental misuse. Strike a line through the front of the document and annotate as superseded. File in descending date order behind the current protocol or in a separate section if required (file note required if an alternate location is used.) An Amendment Tracker Log should be implemented to record all amendments to trial documentation. This should include the version and date of the document, date of REC, R&I and MHRA approval (if applicable) and date implemented at site, allowing research teams to successfully manage version control to ensure the most current approved document is in use. A template amendment tracker log can be located on the R&I website for reference. 2.3 Blank Patient Information Sheet (PIS), Informed Consent Form (ICF) and GP letter (final and amendments) Store copies of all template versions of the PIS/ICF and GP letter used throughout the trial in your ISF (marked as superseded where appropriate) All information provided to the patient must be localised with the LTHT headers before use. V1.0 (131021) Page 5 of 12
6 2.3.3 The PIS,ICF and GP letter should be version controlled, with the version number and date updated each time the document is amended For information on how to construct a PIS and Consent Form and what information should be included, please see the template version located on the R&I website A template consent form can also be located on the NRES website. 2.4 Other Patient Related Documentation Examples of documents to be stored in this section are; patient card, diary card, adverts, posters, dosing instructions, questionnaires Template versions of these documents should be stored in the TMF as master copies and be ethically approved versions. 2.5 Original Signed Consent Forms Within LTHT it is recommended that the original signed consent forms be stored in the TMF/ISF (with a copy provided to the patient and a copy filed within the patients medical notes along with the PIS and GP letter) Any member of staff obtaining consent for a clinical trial involving an Investigational Medicinal Product (IMP) must: - Complete the Trusts Informed Consent Workshop or the NIHR GCP Training (which incorporates the relevant Informed Consent Slides), - Be delegated to obtain consent by the CI/PI - Be appropriately qualified to undertake the task (e.g. research nurses are only permitted to obtain consent if this is clear in the trial protocol and REC application) Whilst completing and / or filing any signed consent forms please check the following aspects: - All fields are complete and refer to the correct ethically approved PIS in use. - Investigator and patient sign the form on the same date (patient must personally sign and date their part of the form). - The member of staff obtaining consent is on the staff delegation log - All boxes are initialled by the patient (none left blank and none ticked rather than initialled.) Errors in consent should be rectified if possible and explained via a file note. V1.0 (131021) Page 6 of 12
7 2.6 Contracts and Financial Agreements: Contracts (signed copies) must be stored within the ISF / TMF to document agreements and financial arrangements between the investigator / institution, Sponsor and third party sub-contractors if applicable. 2.7 Sponsor Correspondence and Approvals: Please file a copy of the Confirmation of Sponsorship letter and other relevant documents within the ISF for Leeds Sponsored trials The original R&I approval and approval of all substantial amendments must also be filed to provide a full audit trail of the documents used. 2.8 Regulatory Approvals and Correspondence: The MHRA Clinical Trials Application, approval letters (initial and amendments) and correspondence (e.g. response to notification for grounds for non-acceptance) must be filed within the ISF for confirmation and audit trail purposes Notification of Substantial Amendment Forms and any other correspondence (including sponsor review forms) surrounding amendments must also be filed. 2.9 Research Ethics Approvals and Correspondence: REC approval letters (initial and amendments) and associated correspondence (e.g. response to provisional/conditional approval letters, completed REC form) must be filed within the ISF to document that the trial has been subject to REC approval and granted favourable opinion. It will also identify which version numbers of documents are approved Notification of Substantial Amendment Forms and any other correspondence (including sponsor review forms) surrounding amendments must also be filed General Correspondence: Relevant communication must be stored to document any agreements or significant discussions regarding the trial administration, protocol violations, potential serious breaches, trial conduct and adverse event reporting File any s, letters, newsletters which contribute to the reconstruction of the trial Avoid duplication (e.g. chain s) and file in date order with the most recent communication on top. V1.0 (131021) Page 7 of 12
8 2.11 Staff Authorisation Log / Delegation Log and CVs / GCPs: The staff delegation log allows the PI/CI to delegate specific trial tasks to members of the research team. A template log can be obtained from the R&I website. This acts as a signature log allowing staff signatures to be cross referenced and verified when seen on trial documents e.g. Case Report Form (CRF) corrections/ entries made into medical notes The tasks assigned must be appropriate to the skills, experience and qualifications of the member of staff. Therefore signed and dated CVs and GCP training certificates must be filed for every member of staff listed. CVs and GCP training should be updated every two years The delegation log must be signed and dated by the CI/PI for each member of trial staff to confirm they are authorised to work on the trial The delegation log must be updated to include new members of staff and stop dates. No member of staff should commence trial related activities without first completing this log Remember to include the lead pharmacist to cover any pharmacy related tasks e.g. dispensing, drug accountability etc Screening Logs and Patient log: A Trial Screening Log or Pre-Screening Log can be used to record patients who were approached/screened but not entered onto the trial e.g. they later declined to participate or failed pre-screening. Full names and identifiable information must not be recorded and stored in the ISF for any patient who has not consented to the trial (initials and date of birth are acceptable) Capture the reason why a patient was not consented / randomised on the log to illustrate recruitment patterns or problems with the design of the trial e.g. numerous patients failing the same inclusion / exclusion criteria which may require a protocol amendment A Patient Identification Log must also be maintained and filed confirming which patients were enrolled. Typical fields include: patient name, patient trial number, consent date and randomisation date Patient logs must not be sent off the NHS site e.g. to the trial sponsor, so as not to breach patient confidentiality Phamacovigilance: File blank Serious Adverse Event (SAE) Forms and SAE reporting procedures within the site file. Please ensure you have the most current version filed containing the correct sponsor contact/fax details. V1.0 (131021) Page 8 of 12
9 Your trial protocol must include a safety reporting section explaining how both Adverse Events (AEs) and Serious Adverse Events (SAE) are defined and reported It is useful to maintain an SAE log documenting the following points: - Description of SAE - Causality/seriousness - Start Date - Date reported to the trial sponsor - Date SAE resolved If an initial report is submitted, please ensure a follow up report is forwarded to the Sponsor once new information becomes available. SAEs should be followed up to resolution / stop date and the SAE must be fully documented within the patient s medical notes to enable source data verification (IMP) Accountability Logs, SPC and IBs Pharmacy related documents e.g. drug accountability log, shipping records, disposal logs, dispensing procedures, temperature logs etc are often maintained in a separate pharmacy file held within the clinical trials pharmacy department you should check if this is happening Drug Accountability Logs must fully document what medication was received by the site, patient, when and where, as well as any medication returned to the Sponsor or destroyed. The running total of medication held at pharmacy is also recorded Pharmacy must maintain temperature records to confirm the IMP is stored within the correct parameters as instructed by the dispensing procedure, IB or SPC. However, if the IMP is to be stored with the research team separate temperature records must be maintained. Liaise with LTHT pharmacy for guidance Any equipment used i.e. temperature probes and fridges must be regularly serviced and calibrated for use. Please ensure all servicing and calibration records are stored within the file If your department is responsible for storing or dispensing the IMP (e.g. IMP is stored in clinic or theatre for the duration of the trial), separate accountability records should be maintained to ensure the whole IMP pathway is documented Investigator Brochures /Summary of Product Characteristic for all IMPs used in the trial must also be stored in the ISF/TMF and updated when necessary. Other documents such as Good Manufacturing Documents, Qualified Person Release, Certificate of Analysis, Manufacturing Authorisation and IMP License may also be required. V1.0 (131021) Page 9 of 12
10 2.15 Central Laboratory and Local Analysis of Biological Samples: For any lab equipment used i.e. freezers and centrifuges please ensure all calibration records are stored within the ISF/TMF If external laboratories/analysis is used please ensure 3 rd party contracts are established with the organisation and that they are stored within the ISF Please store copies of the trial specific lab sample request forms in the ISF along with confirmation of sending/receipt Randomisation and Un-blinding File randomisation and code break instructions, template unblinding form (if applicable), out of hours contacts and registration numbers / confirmation of randomisation faxes within the site file Case Report Form: A blank template CRF should be stored in the site file. Only information requested on the CRF should be recorded, and it should not contain any patient identifiable information The CRF should directly match the protocol and only request information which is specifically required. More detailed guidance on how to construct a CRF can be obtained from the QA department / R&I website (CTGN 44) 2.18 Quality Assurance / Audit / Inspections and Monitoring: Please keep a record of any monitoring visit or audit reports within the site file For Leeds Sponsored trials this will include a site initiation visit report and any routine monitoring visit action reports Store both the Monitoring Action Reports and completed responses showing what corrective action was implemented at site for confirmation purposes TSC / DMC Correspondence Trial Steering Committees usually meet on an annual basis (more frequent for high risk studies please consult your trial protocol). Meeting minutes and significant discussions must be stored within the ISF Database and Data Record Logs A blank copy of any trial database and any associated documentation i.e. validation and management, should be filed within this section. V1.0 (131021) Page 10 of 12
11 2.23 Statistical Analysis Plan A copy of the statistical analysis plan or relevant section of the protocol describing the statistical considerations of the trial must be filed within the ISF Safety Reporting: Copies of the annual Development Safety Update Reports (DSUR) sent to the MHRA and executive summary sent to the REC must be filed within the ISF including the SAE line listings. For older trials any annual progress reports / safety reports must also be filled together with the associated MHRA/REC correspondence. 3.0 Documentation to be stored following trial closure: 3.1 Trial Closure Please complete and file the declaration of end of trial form and close down monitoring visit report within the ISF. The Sponsor close down visit will ensure the ISF / TMF is complete and fit for archiving. 3.2 Publications Once data from the trial has been published any relevant documentation must be filed within the ISF. 3.3 Archiving Please refer to the archiving section of your trial protocol or the separate archiving SOP available from QA / R&I website. 4.0 General Trial Documentation Tips: File documentation within the ISF subsections in date order with the most recent document on top. Documents can be stored electronically e.g. copies of the IB/superseded protocols to save space within the ISF however this must be referenced within the ISF via a file note and all documentation must be printed out as hard copy prior to archiving/requested by the sponsor/mhra. When new trial documentation is approved for use do not discard previous versions Instead mark the old copies as superseded by striking a single line across the front of the document and annotating as superseded. When creating and updating trial documents please include version control e.g. version 1.0 (01/01/2013). When the document is amended please update BOTH the date and version number in the footer (e.g. version 2 (01/02/2013)) V1.0 (131021) Page 11 of 12
12 5.0 As an Investigator you must ensure the following: A site file is made for each CTIMP containing all essential documents, complete with a contents list for easy navigation. The file will be constructed at the start of the trial and be updated in a timely manner A staff authorisation log / delegation log will be created and maintained detailing all staff working on the trial. Training documentation will be updated every two years, or where applicable. All formal trial documents (including the information provided to the patient) must receive the necessary approvals e.g. Sponsor/R&I/REC/MHRA prior to implementation, including any substantially amended documents. The site file will not contain patient identifiable detail (such as sections of the medical notes or correspondence naming the patient.) Section D References MHRA Good Clinical Practice Guide 2012 E6 Guideline for Good Clinical Practise version 2.1 August 2011 Section E CI CRF CTIMP DMC DSUR GCP GP IB ISF ICF LTHT MHRA PI PIS QA R&I REC SAE SOP SPC SSI SUSAR TSC UoL Definitions Chief Investigator Case Report Form Clinical Trial of an Data Monitoring Committee Development Safety Update Report Good Clinical Practise General Practitioner Investigator Brochure Investigator Site File Informed Consent Form Leeds Teaching Hospitals Trust Medicines and Healthcare products Regulatory Agency Principal Investigator Patient Information Sheet Quality Assurance Research and Innovation Research Ethics Committee Serious Adverse Event Standard Operation Procedure Summary of Product Characteristics Site Specific Information Suspected Unexpected Serious Adverse Reaction Trial Steering Committee University of Leeds V1.0 (131021) Page 12 of 12
Investigator Site File Index (CTIMP)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol Current version plus all previous versions (or provide file note to detail location of previous
More informationDetails: Approval: Distribution & Storage:
Details: Author: Neville Young Quality Assurance Manager SOP Pages: Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person approving
More informationStandard Operating Procedure
Standard Operating Procedure Number: UM/UoM TMF/SOP08/6.0 Title: The Creation and Maintenance of Trial Master Files and Essential Documentation Version: 6.0 () Effective Date: Author: Mrs Catherine Barrow
More informationStudy Files and Filing
Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm
More informationInvestigator Site File Index (Medical Devices)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol (Clinical Investigation Plan) Current version plus all previous versions (or provide file note
More informationOnce notified of the end of trial, a Research Manager, on behalf of the Sponsor, will contact the CI to arrange a close down monitoring visit.
1. INTRODUCTION This SOP has been produced in accordance with the requirements of The Medicines for Human Use (Clinical Trials) Regulations 2004, Medicines for Human Use (Clinical Trials) Amendment Regulations
More informationTrial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products
1 Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products SECTION TITLE DOCUMENTS 1. Contact List Including details of relevant study site staff, responsible
More informationIndex of Standard Operating Procedures for all research Sponsored by the UHL
University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the October Please note that with effect from 2015, all SOPs and Appendices use the same
More informationIndex of Standard Operating Procedures for all research Sponsored by the UHL
University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the March Please note that with effect from 2015, all SOPs and Appendices use the same
More informationRESEARCH AUDIT Standard Operating Procedure
Reference Number: UHB 236 Version Number: 2 Date of Next Review: 17 th Oct 2020 Previous Trust/LHB Reference Number: N/A RESEARCH AUDIT Standard Operating Procedure Introduction and Aim As a legal Sponsor
More informationLOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office
LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE Loughborough University (LU) Research Office SOP 1024 LU Study Closedown and End of Study Reporting for NHS Research Sponsored by Loughborough
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 17. Study Close Down According to ICH Good Clinical Practice (GCP)
More informationInspections: an academic perspective
Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk
More informationTrial Master File. SOP No. SOP 7
Trial Master File SOP Title Trial Master File SOP No. SOP 7 Author Consultation Departments Date approved Julia Farmery Lincolnshire Clinical Research Facility, Research and Development, Trust consultants
More informationESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL
ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL THIS INFORMATION SHEET (ISR-RG-014) HAS BEEN TAKEN DIRECTLY FROM THE ICH- GUIDELINE* WITH ADDITIONAL COMMENTS ADDED BY THE RESEARCH GOVERNANCE
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Essential Documentation and Creation and Maintenance of Trial Master File SOP Number: 13 Version Number: 2.0 Supercedes:
More informationResearch Study Close-down and Archiving Procedures
Title: Research Study Close-down and Archiving Procedures Outcome Statement: To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Maintaining Study Files SOP-RES-014 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January 2018 Author(s)
More informationSTANDARD OPERATING PROCEDURE SOP 410. Set up and Initiation of an Investigator Site
STANDARD OPERATING PROCEDURE SOP 410 Set up and Initiation of an Investigator Site Version 1.2 Version date 4.01.2017 Effective date 5.07.2017 Number of pages 13 Review date July 2019 Author Role NNUH
More informationSPONSOR INVESTIGATIONAL MEDICINAL PRODUCT (IMP) MANAGEMENT
SPONSOR INVESTIGATIONAL MEDICINAL PRODUCT (IMP) MANAGEMENT DOCUMENT NO.: GS010 v1.0 AUTHOR: Vikki Young ISSUE DATE: 28 MAY 2018 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research &
More informationConducting Clinical Trials of Investigational Medicinal Products
Title: Outcome Statement: Written By: Reviewed By: Conducting Clinical Trials of Investigational Medicinal Products Researchers in the Trust and research partners will be informed about the procedures
More informationSTANDARD OPERATING PROCEDURE. STH Researcher. Investigator Site File
Research Department STANDARD OPERATING PROCEDURE STH Researcher SOP History CSUH 00/016 SOP Number A116 Created STH Research Department (TL) Reviewed by STH Research Department (AL) 06 August 2009 Superseded
More informationTrial Committees SOP Number: 47 Version Number: 2.0 Effective Date: 01/02/2017 Review Date: 01/02/2019
Standard Operating Procedures (SOP) for: Trial Committees SOP Number: 47 Version Number: 2.0 Effective Date: 01/02/2017 Review Date: 01/02/2019 Author: Reviewer: Reviewer: Authorisation: Name / Position:
More informationCode break is also known as breaking the blind and involves un-blinding a participant so that the treatment allocation is made known.
1. INTRODUCTION This SOP has been produced in accordance with Medicines for Human Use (Clinical Trials) Regulations 2004. This SOP will outline the procedure for breaking the study code in a NUH sponsored
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 14. Amendments to Research Studies
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 14. Amendments to Research Studies Amendments are changes made
More informationStandard Operating Procedure. GCP Auditing of Research Studies
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-16-003 GCP Auditing of Research Studies SOP effective: 09 June 2017 Review date: 09 June 2019 SOP author signature: SIGNED COPY HELD WITHIN
More informationDate: 23 rd December 2014 Version 5 Page 1 of 8 STANDARD OPERATING PROCEDURE FOR TRIAL INITIATION AND SITE SET UP (NWORTH 3.03)
Page 1 of 8 STANDARD OPERATING PROCEDURE FOR TRIAL INITIATION AND SITE SET UP (NWORTH 3.03) Approvals Principal Author Name: D. Skelhorn Signature: D. Skelhorn Date: 22/12/2014 Quality Assurance Officer
More informationR&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Trial Closure and End of Trial SOP021 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration
More informationStandard Operating Procedure for Archiving
Standard Operating Procedure for Archiving SOP name: NWORTH07/19 archiving Version 2 Authorship Team: Angela Gliddon & Rhiannon Whitaker Meeting date reviewed 16 th April 2008 Designated NWORTH member
More informationDate: 21 st May 2014 Version: 5 Page 1 of 11. Principal Author Name D. Skelhorn Signature: D. Skelhorn Date: 22 nd May 2014
Date: 21 st May 2014 Version: 5 Page 1 of 11 STANDARD OPERATING PROCEDURE FOR MONITORING CLINICAL TRIALS (NWORTH 3.07) Approvals Principal Author Name D. Skelhorn Signature: D. Skelhorn Date: 22 nd May
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Trial Master File & Investigator Site File SOP number: TM 001 SOP category: Trial Management Version number: 03 Version
More informationIMP Management and Accountability
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL
Assemble Essential Documents in Trial Master File (TMF) Appendix 1 ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 8.2 Before the Clinical Phase of the Trial Commences During this planning stage
More informationDevelopment Safety Update Report Guidance
Development Safety Update Report Guidance This document provides instructions for the preparation and submission of a Development Safety Update Report (DSUR) for a Clinical Trial of an Investigational
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Archiving and the Destruction of Records SOP-RES-028 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January
More informationManagement and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility
Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility Document Detail Document type Standard Operating Procedure CRF-STU-SOP-1: Management and Accountability
More informationManagement and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility
Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility Document Detail Document type Standard Operating Procedure CRF-STU-SOP-1: Management and Accountability
More informationPharmacovigilance and safety reporting for sponsored ATIMPs/CTIMPs
Joint Research Management Office (JRMO) Standard Operating Procedure (SOP) for: Pharmacovigilance and safety reporting for sponsored ATIMPs/CTIMPs SOP Number: 26a Version Number: 13.0 Effective Date: 31
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Notification and Premature Discontinuation of a Study SOP-RES-025 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016
More informationRDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Product (CTIMPs)
RDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: Document Summary: Document
More informationSTUDY DOCUMENTS. DOCUMENT NO.: CR007 v4.0. Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 EFFECTIVE DATE: 21 MAR INTRODUCTION
STUDY DOCUMENTS DOCUMENT NO.: CR007 v4.0 AUTHOR: Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint office
More informationNHS Tayside Effective Date: 24/7/2009
1. PURPOSE This document describes the procedure for the supply, transport and storage of Investigational Medicinal Product (IMP). This SOP complies with the principles of Good Clinical Practice, Good
More informationEnd of Study Notification, Close-Out and Reporting Sponsored Research. Noclor/Spon/S11/01. SOP Reference ID:
End of Study Notification, Close-Out and Sponsored Research SOP Reference ID: Noclor/Spon/S11/01 Version Number 1.0 Effective Date: 6 th June 2016 It is the responsibility of all users of this SOP to ensure
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Training and Development SOP-QMS-007 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s)
More informationRDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs. Greater Manchester Mental Health NHS Foundation Trust
RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs
More informationSite Initiation and Activation
Site Initiation and Activation Clinical Trials SOP Reference ID: Noclor/Spon/S05/01 Version Number 1.0 Effective Date: 23 rd February 2016 It is the responsibility of all users of this SOP to ensure that
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Non Compliance and Serious Breach Reporting SOP-RES-017 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov
More informationStandard Operating Procedure. Vendor Management
REFERENCE: VERSION NUMBER: 2.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager, Contracts & Quality Management Officer REVIEWED BY: Research & Innovation Group APPROVED BY:
More informationResearch & Development. J Illingworth and S Moffat. Research, pharmacy and R&D staff
Department Title of SOP Research & Development SOP reference no: R&D GCP SOP 08 Authors: Reviewed by Current version number and date: J H Pacynko J Illingworth and S Moffat Version 4, 04.02.19 Next review
More informationWriting a Protocol for CTIMPs
REFERENCE: VERSION NUMBER: 4.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: REVIEWED BY: APPROVED BY: CONTROLLER: Clinical Trials Manager; Clinical Trials Officer Research & Innovation Group
More informationStandard Operating Procedure. GCP Auditing of Research Studies. SOP effective: 23rd January 2018 Review date: 23rd January 2020
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-16-005 GCP Auditing of Research Studies SOP effective: 23rd January 2018 Review date: 23rd January 2020 SOP author signature: Signed copy
More informationDocument Title: Handling of drug alerts and recalls of IMPs
Document Title: Handling of drug alerts and recalls of IMPs Document Number: SOP074 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager,
More informationInvestigational Medicinal Product (IMP) Management Standard Operating Procedure
Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support
More informationSTUDY CLOSURE AND ARCHIVING
STUDY CLOSURE AND ARCHIVING DOCUMENT NO.: CR009 v2.0 AUTHOR: Lynn Smith ISSUE DATE: 15 August 2016 EFFECTIVE DATE: 29 August 2016 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research
More informationDocument Title: Site Recruitment and Initiation for Papworth Sponsored Studies
Document Title: Site Recruitment and Initiation for Papworth Sponsored Studies Document Number: SOP015 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For
More informationStandard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs
Standard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs For Completion by SOP Author Reference Number Version Document Author(s) Document Reviewer(s) PHT/RDSOP/001
More informationTrial oversight SOP for HEY-sponsored CTIMPs
R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system
More informationStandard Operating Procedure. SOP effective: 23 July 2015 Review date: 23 July 2017
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-12-002 Archiving Clinical Research Documents SOP effective: 23 July 2015 Review date: 23 July 2017 SOP author signature: SIGNED COPY HELD
More informationSTANDARD OPERATING PROCEDURE
Research and Development STANDARD OPERATING PROCEDURE PHARMACOVIGILANCE S22 Post holder responsible for SOP: Anoushka Tepielow Position: Assistant R&D Manager Author: Anoushka Tepielow Position: Assistant
More informationStandard Operating Procedure. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-18-002 Randomisation and Code Breaking SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature: SIGNED COPY HELD
More informationRD SOP32 Gaining MHRA Approval
RD SOP32 Gaining MHRA Approval Version Number: 1.0 Name of originator/author: Dr Lloyd Gregory Name of responsible committee: R&I Committee Name of executive lead: Medical Director & Director of Quality
More informationJoint Research Office of Doncaster & Bassetlaw
Page 1 of 11 Hospitals NHS, Rotherham Doncaster & South Humber NHS and NHS Signatures: Role Name Function Date (DD-MM-YYYY) Signature Author Amy Beckitt Clinical Research Development Manager Reviewer Dr
More informationDocument Number: SOP/RAD/SEHSCT/003 Page 1 of 9 Version 2.0
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Archiving Study Documents SOP Number: 3 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationThe European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:
The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR
More informationR&D Administration Manager. Research and Development. Research and Development. NHS Staff Trust-Wide THIS IS A CONTROLLED DOCUMENT
Document Title: Document Number: Research Protocol Design for Papworth Sponsored Studies SOP019 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by:
More informationOFFICE FOR RESEACH PROCEDURE. Site Initiation and Close-out
OFFICE FOR RESEACH PROCEDURE Site Initiation and Close-out 1. Purpose: To describe the procedures related to site initiation and close-out of a clinical trial. 2. Scope: Applicable to all phases of clinical
More informationMarie-Claire Rickard (RG and GCP Manager) Rachel Fay (RG and GCP Manager) Elizabeth Clough (R&D Governance Operations Manager)
Standard Operating Procedures (SOP) for: For researchers: Pharmacovigilance and Safety Reporting for Sponsored CTIMPs/ATMP SOP Number: 026a Version Number: 12.0 Effective Date: 21/4/16 Review Date: 21/4/18
More informationSally Burtles, Director of Research Services & Business Development
Standard Operating Procedures (SOP) for: Process for Researchers - Amendments for Sponsored Studies (including halting studies and early termination) SOP Number: 17c Version Number: 2.0 Effective Date:
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL) Research Governance
More informationRecording, Managing and Reporting Adverse Events in the UK
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationStandard Operating Procedure. SOP effective: 21 December 2017 Review date: 21 December 2019
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-12-003 Archiving Clinical Research Documents SOP effective: 21 December 2017 Review date: 21 December 2019 SOP author signature: SIGNED
More informationAnnex IV to guidance for the conduct of good clinical practice inspections sponsor and CRO
23 August 2017 EMA/431267/2016 Annex IV to guidance for the conduct of good clinical practice inspections sponsor Adopted by GCP Inspectors Working Group (GCP IWG) 29 November 2017 Keywords GCP inspection,
More informationInvestigator s Responsibility
Investigator s Responsibility Introduction Investigator s Qualifications Clinical Trial Agreement Adequate Resources Medical Care of Trial Subjects Communication with IRB/IEC Study Initiation Patient Recruitment
More informationSTANDARD OPERATING PROCEDURE SOP 725 CAPACITY, CAPABILITY AND RISK ASSESSMENT OF TRIALS HOSTED BY NNUH
STANDARD OPERATING PROCEDURE SOP 725 CAPACITY, CAPABILITY AND RISK ASSESSMENT OF TRIALS HOSTED BY NNUH Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 9 pages Review date
More informationSource Documents and Regulatory Binders October 6, 2016
Source Documents and Regulatory Binders October 6, 2016 Lisa Wilson, Regulatory Lead, Clinical Trials Office and Mark Alger, CRC, Clinical Trials Office Essential Documents AKA: the stuff in the Reg Binder
More informationR&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:
Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents
Guidance for s Regulatory File Essential s All principal investigators must maintain a regulatory binder or file system, which contains all study documentation. These records may be reviewed at the time
More informationStandard Operating Procedure
Standard Operating Procedure Number: UM/UoM Pharmacovigilance_Reporting Adverse Events/SOP10(i)/6.0 Title: Standard Operating Procedure for Identifying, Recording and Reporting Adverse Events for Clinical
More informationPhase 1 studies and The Over- Volunteering Prevention System (TOPS)
Research Department STANDARD OPERATING PROCEDURE Phase 1 studies and The Over- Volunteering Prevention System () SOP Number C129 Version Number 1.0 Date effective 18 June 2018 Author Luke Barron Related
More informationStandard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: SOP-QA-9 Version No: 1
Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies SOP Number: SOP-QA-9 Version No: 1 Author: Date: 1-9-15 (Carole Edwards, Lead Research Nurse, NHS Grampian)
More informationECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies
ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies SOP number: ECTU TM 17 Signature Date Authored by: Holly Ennis, Trial Manager 6 th Sept 2017 Reviewed by: Laura Forsyth, Trial Manager
More informationStandard Operating Procedures Guidelines for Good Clinical Practice
SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA
More informationJoint Research Office
Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Tel: 020 3447 5557 Fax: 020 3447 9937 Website: www.uclh.nhs.uk; www.ucl.ac.uk; www.ucl.ac.uk/jro Postal
More informationSTANDARD OPERATING PROCEDURE SOP 310
STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April
More informationCompliance and Quality Monitoring: What, Why, When, and How
Compliance and Quality Monitoring: What, Why, When, and How Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Research Institute, University
More informationSTANDARD OPERATING PROCEDURE SOP 320. Developing a Research Protocol
STANDARD OPERATING PROCEDURE SOP 320 Developing a Research Protocol Version 2.1 Version date 26.03.2017 Effective date 26.03.2017 Number of pages 14 Review date April 2019 Author NNUH UEA Joint Research
More informationAudit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.
Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,
More informationCOMBINED RISK ASSESSMENT
COMBINED RISK ASSESSMENT DOCUMENT NO.: GS002 v3.0 AUTHOR: Lorn Mackenzie ISSUE DATE: 04 AUG 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint
More informationStandard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: UoA-NHSG-SOP-010 Version No: 2
Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies SOP Number: UoA-NHSG-SOP-010 Version No: 2 Author: Date: 27 th March 2015 (Carole Edwards, Lead Research
More informationStandard Operating Procedure
Standard Operating Procedure Title: Clinical Site Monitoring Status: PRIVATE Author Name: Audrey Strader Approver Name: Christine Kubiak Document no.: CSM 02 Effective date: 11/01/2016 Review Date (if
More informationAuthor Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document
SOP Title: Investigator s Brochure Content, Design, Amendments, Filing & Distribution Author: Clinical Research and Development Office (CRDO) Author Signature: Date: 10 October 2017 The author is signing
More informationMulti-Site Coordination Process. Drafted by: Ester Dimayuga Page 1 of 18
Multi-Site Coordination Process Drafted by: Ester Dimayuga Page 1 of 18 MULTI-SITE COORDIATIO (MSC) REGULATOR PROCESS CTO-Regulatory notifies MSC of trial with UMCC as coordinating center MSC prepares
More informationSafety Reporting Part 1: For Clinical Trials of Investigational Medicinal Products (CTIMPs)
Part 1: For Clinical Trials of Investigational Medicinal Products (CTIMPs) Version 1.4 Effective date: 1 December 2011 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision
More informationNIS Considerations - Bulgaria
NIS Considerations - Bulgaria An overview of the considerations when conducting Noninterventional Studies in Bulgaria Stuart McCully CHCUK Ltd NIS-C-BG-2014 1 Table of Contents Disclaimer 5 Copyright 5
More informationThe role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
in partnership with The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU) CTRad Clinical Trials Workshop 14/10/2014 What is
More informationRegulatory Binder: Set-up and Maintenance
Regulatory Binder: Set-up and Maintenance Introduction Federal and state regulations, institutional policy, and good clinical and research practices require investigators to maintain documents related
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Creation, Review and Management of Standard Operating Procedures for Research SOP Number: 1 Version Number: 2.0 Supercedes:
More informationMarie-Claire Good, RG and GCP Manager James Rickard, Deputy Chief Pharmacist Technical Services Cheryl Lawrence, Senior Research Pharmacist
Standard Operating Procedures (SOP) for: IMP Management BH/QMUL Sponsored CTIMPs SOP Number: 42a Version Number: 3.0 Effective Date: 14 th August 2017 Review Date: 14 th August 2019 Author: Reviewer: Reviewer:
More informationTemperature Monitoring (Clinical Trials)
York Foundation Trust R&D Unit Standard Operating Procedure Pharm/S48 Temperature Monitoring (Clinical Trials) IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING
More information